Oliviero James F III 4
4 · Checkpoint Therapeutics, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Sale
COMMON STOCK
2025-04-02$4.04/sh−15,090$60,964→ 3,759,929 total
Footnotes (2)
- [F1]In connection with the vesting of restricted shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Includes shares of restricted common stock, which vest over various time periods.